Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
(C6H10O3)n
CAS Number:
NACRES:
NA.75
PubChem Substance ID:
UNSPSC Code:
12352207
MDL number:
Product Name
Poly(2-hydroxyethyl methacrylate), BioReagent, powder, suitable for cell culture
InChI
1S/C6H10O3/c1-5(2)6(8)9-4-3-7/h7H,1,3-4H2,2H3
SMILES string
CC(=C)C(=O)OCCO
InChI key
WOBHKFSMXKNTIM-UHFFFAOYSA-N
biological source
synthetic (organic)
product line
BioReagent
form
powder
technique(s)
cell culture | mammalian: suitable
solubility
ethanol: 120 mg/mL
density
1.15 g/mL at 25 °C (lit.)
Quality Level
Looking for similar products? Visit Product Comparison Guide
Application
Poly(2-hydroxyethyl methacrylate) has been used:
- as a nonadhesive substrate in the preparation of single cell suspensions
- to implant into mice cornea for corneal micropocket assay
- to coat the well plates for sphere assay using adipose-derived mesenchymal stem cells
Biochem/physiol Actions
Poly(2-hydroxyethyl methacrylate) is an acrylic compound and has dental usage. It is mainly used to inhibit cell adhesion to growth surfaces in culture vessels.
Physical form
Water-swellable polymer. Hydrogel.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors
Rungarunlert S, et al.
World journal of stem cells, 1(1), 11-11 (2009)
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
Ignatova Tatyana N, et al.
Glia, 39(3), 193-206 (2002)
VAP-1-Mediated M2 Macrophage Infiltration Underlies IL-1beta-but Not VEGF-A-Induced Lymph-and Angiogenesis
Nakao S, et al.
The American Journal of Pathology, 178(4), 1913-1921 (2011)
Manuele Giuseppe Muraro et al.
Stem cells translational medicine, 1(8), 592-603 (2012-12-01)
Increasing evidence that cancers originate from small populations of so-called cancer stem cells (CSCs), capable of surviving conventional chemotherapies and regenerating the original tumor, urges the development of novel CSC-targeted treatments. Screening of new anticancer compounds is conventionally conducted on
Handbook of Occupational Dermatology, 564-564 (2013)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service